Published in Arthritis Res Ther on April 28, 2006
Radiologic observation: repair of focal bone erosions after humanized antitumor necrosis factor antibody adalimumab therapy in a patient with rheumatoid arthritis. Clin Rheumatol (2009) 1.66
Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am (2010) 1.38
PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. PLoS One (2013) 1.11
Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum (2012) 1.08
MR imaging of erosions in interphalangeal joint osteoarthritis: is all osteoarthritis erosive? Skeletal Radiol (2007) 1.00
Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies. Clin Rheumatol (2008) 1.00
Advances in the medical treatment of rheumatoid arthritis. Hand Clin (2011) 0.93
Bone erosion repair with adalimumab in rheumatoid arthritis. Clin Rheumatol (2010) 0.92
Rheumatoid arthritis: Repair of erosion in RA--shifting the balance to formation. Nat Rev Rheumatol (2011) 0.87
Proteomics in Rheumatoid Arthritis Research. Immune Netw (2015) 0.83
The paediatric wrist revisited--findings of bony depressions in healthy children on radiographs compared to MRI. Pediatr Radiol (2012) 0.79
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts. Clin Rev Allergy Immunol (2016) 0.78
Tofacitinib prevents radiographic progression in rheumatoid arthritis. J Korean Med Sci (2013) 0.78
Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.77
Mediators of inflammation and bone remodeling in rheumatic disease. Semin Cell Dev Biol (2015) 0.76
Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review. Clin Rev Allergy Immunol (2016) 0.76
Rheumatoid Arthritis Revisited - Advanced Imaging Review. Pol J Radiol (2016) 0.75
Assessing rheumatologists and radiologists agreement rate regarding the diagnosis of focal bone erosions and osteopenic changes using hand X-rays radiography in patients with rheumatoid arthritis. Rheumatol Int (2013) 0.75
Skeletal complications of rheumatoid arthritis. Osteoporos Int (2017) 0.75
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med (2000) 10.21
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum (2004) 7.13
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum (1998) 5.40
Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol (1996) 3.63
Epidemiology and genetics of rheumatoid arthritis. Arthritis Res (2002) 3.37
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum (1992) 3.05
Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum (1996) 2.77
Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol (1996) 2.55
Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol (2001) 2.54
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol (2004) 2.20
Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis (2004) 2.08
The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum (2000) 1.97
Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum (1998) 1.87
Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy. Arthritis Rheum (1996) 1.64
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol (2002) 1.63
Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (2000) 1.62
Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology (Oxford) (1999) 1.57
Identification of wrist and metacarpophalangeal joint erosions using a portable magnetic resonance imaging system compared to conventional radiographs. J Rheumatol (2004) 1.42
Use of the radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold. Arthritis Rheum (1990) 1.34
What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis (2001) 1.30
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions. J Rheumatol (2003) 1.25
Magnetic resonance imaging in the assessment of rheumatoid arthritis--a comparison with plain film radiographs. Br J Rheumatol (1991) 1.18
Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. J Rheumatol (1988) 1.12
The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol (1997) 0.99
Progression and repair in radiographs of hands and forefeet in early rheumatoid arthritis. J Rheumatol (1995) 0.97
Healing of joint erosions in rheumatoid arthritis. Arthritis Rheum (1990) 0.96
Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol (1993) 0.96
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis. Expert Opin Drug Saf (2004) 0.95
Healing of erosions in rheumatoid arthritis. Ann Rheum Dis (2000) 0.93
Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol (2001) 0.89
Assessment of radiographs in longitudinal observational studies. J Rheumatol Suppl (2004) 0.88
Magnetic resonance imaging of the wrist in rheumatoid arthritis: demonstration of progression between 1 and 6 years. Skeletal Radiol (2004) 0.80
Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force. J Rheumatol (2001) 0.80
Magnetic resonance imaging of soft tissue changes in rheumatoid arthritis wrist joints. Semin Musculoskelet Radiol (2001) 0.79
Healing of articular erosions after ceasing to use suspected immunological adjuvants. Clin Rheumatol (1990) 0.77
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Respir Care (2012) 2.00
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet (2013) 1.93
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma (2010) 1.55
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res (2013) 1.45
Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma (2012) 1.40
Prognostic factors in diffuse large B-cell lymphoma treated by risk-adopted therapy. Intern Med (2006) 1.39
Behçet disease: evolution of clinical manifestations. Medicine (Baltimore) (2011) 1.33
RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene (2007) 1.25
Pathology of asthma. Front Microbiol (2013) 1.25
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica (2009) 1.22
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis. Mod Rheumatol (2011) 1.20
Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem (2002) 1.19
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A (2013) 1.15
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol (2007) 1.14
Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer (2011) 1.13
Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther (2002) 1.12
Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther (2005) 1.11
Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM. Biochem J (2002) 1.11
Central nervous system involvement in diffuse large B-cell lymphoma. Eur J Haematol (2010) 1.11
Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol (2010) 1.11
Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1. Cancer Sci (2010) 1.10
Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol (2002) 1.10
Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol (2007) 1.08
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res (2010) 1.08
Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med (2006) 1.08
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients. Cancer Sci (2014) 1.08
Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS One (2008) 1.07
Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways. Arthritis Rheum (2012) 1.06
Primary hepatic peripheral T-cell lymphoma treated with corticosteroid. Intern Med (2011) 1.06
Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab--preliminary data. Rheumatol Int (2011) 1.05
Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine (2003) 1.05
Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction. J Cell Biol (2004) 1.03
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. Eur J Haematol (2013) 1.02
Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology (2013) 1.01
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci (2011) 1.00
The first CH domain of affixin activates Cdc42 and Rac1 through alphaPIX, a Cdc42/Rac1-specific guanine nucleotide exchanging factor. Genes Cells (2004) 1.00
Pulmonary hyalinizing granuloma with laryngeal and subcutaneous involvement: report of a case successfully treated with glucocorticoids. Intern Med (2004) 1.00
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 1.00
Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2011) 0.99
[Multiple myeloma presenting as cavernous sinus syndrome]. Rinsho Ketsueki (2006) 0.99
Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum (2007) 0.98
Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum (2006) 0.98
Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology (2009) 0.97
Salmonella enterica serovar Ohio septic arthritis and bone abscess in an immunocompetent patient: a case report. J Med Case Rep (2012) 0.97
Ultrasonography is a potent tool for the prediction of progressive joint destruction during clinical remission of rheumatoid arthritis. Mod Rheumatol (2012) 0.96
Lipoid pneumonia. Lancet (2002) 0.96
Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. Hum Gene Ther (2005) 0.95
The gamma-parvin-integrin-linked kinase complex is critically involved in leukocyte-substrate interaction. J Immunol (2006) 0.95
Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol (2011) 0.94
Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis (Edinb) (2009) 0.93
Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J Allergy Clin Immunol (2008) 0.93
Atypical Burkitt lymphoma arising from follicular lymphoma: demonstration by polymerase chain reaction following laser capture microdissection and by fluorescence in situ hybridization on paraffin-embedded tissue sections. Am J Surg Pathol (2005) 0.93
Proteasome-dependent degradation of alpha-catenin is regulated by interaction with ARMc8alpha. Biochem J (2008) 0.92
R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma. Br J Haematol (2013) 0.92
Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Hematol Oncol (2012) 0.92
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. Ann Rheum Dis (2012) 0.92
Role of 18F-fluoride PET/CT in the assessment of multiple myeloma: initial experience. Ann Nucl Med (2012) 0.90
[Case of intravascular lymphoma diagnosed by transbronchial lung biopsy, with transient spontaneous remission]. Nihon Kokyuki Gakkai Zasshi (2010) 0.90
Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respir Res (2014) 0.90
Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis. Rheumatol Int (2009) 0.89
Possible role of ILK-affixin complex in integrin-cytoskeleton linkage during platelet aggregation. Biochem Biophys Res Commun (2002) 0.89
Intestinal manifestations in systemic lupus erythematosus. Intern Med (2006) 0.89
Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients. Rheumatol Int (2013) 0.89
Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation. Int J Hematol (2013) 0.89
Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J Biochem (2004) 0.88
Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia. Leuk Lymphoma (2003) 0.88
[Usefulness of hematopoietic cell transplantation-specific comorbidity index after allogeneic hematopoietic stem cell transplantation]. Gan To Kagaku Ryoho (2008) 0.87
Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk. Leuk Lymphoma (2011) 0.87
Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro. Life Sci (2002) 0.86
Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum. Leuk Lymphoma (2012) 0.86
Over-expression of PAR-3 suppresses contact-mediated inhibition of cell migration in MDCK cells. Genes Cells (2002) 0.86
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma. Cancer (2002) 0.86
Clinical and pathological roles of Ro/SSA autoantibody system. Clin Dev Immunol (2012) 0.86
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol (2011) 0.85
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol (2010) 0.85
Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Mod Rheumatol (2011) 0.85
Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease. Case Rep Ophthalmol (2011) 0.85
Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era. Eur J Haematol (2013) 0.85
Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus. Int J Rheumatol (2012) 0.85
Armadillo Repeat Containing 8alpha Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins. Open Biochem J (2010) 0.85
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age. Clin Lymphoma Myeloma Leuk (2013) 0.84
[Prognosis of patients with tuberculosis]. Kekkaku (2013) 0.84
Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type. Med Oncol (2014) 0.84
Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific gamma interferon production in cerebrospinal fluid enzyme-linked immunospot assay. Clin Vaccine Immunol (2008) 0.84
SIL index, comprising stage, soluble interleukin-2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B-cell lymphoma. Cancer Sci (2012) 0.84
A case of Poncet's disease (tuberculous rheumatism). Rheumatol Int (2008) 0.84
Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells. Lung Cancer (2010) 0.84